Leicester Research Archive >
College of Medicine, Biological Sciences and Psychology >
Cardiovascular Sciences, Department of >
Published Articles, Dept. of Cardiovascular Sciences >
Please use this identifier to cite or link to this item:
|Title: ||MicroRNA 217 Modulates Endothelial Cell Senescence via Silent Information Regulator 1|
|Authors: ||Menghini, R.|
|Issue Date: ||Oct-2009|
|Publisher: ||American Heart Association|
|Citation: ||MicroRNA 217 Modulates Endothelial Cell Senescence via Silent Information Regulator 1. Rossella Menghini, Viviana Casagrande, Marina Cardellini, Eugenio Martelli, Alessandro Terrinoni, Francesca Amati, Mariuca Vasa-Nicotera, Arnaldo Ippoliti, Giuseppe Novelli, Gerry Melino, Renato Lauro and Massimo Federici. Circulation 2009;120;1524-1532.|
|Abstract: ||Background: Aging is a major risk factor for the development of atherosclerosis and coronary artery disease. Through a microarray approach, we have identified a microRNA (miR-217) that is progressively expressed in endothelial cells with aging. miR-217 regulates the expression of silent information regulator 1 (SirT1), a major regulator of longevity and metabolic disorders that is progressively reduced in multiple tissues during aging.
Methods and Results: miR-217 inhibits SirT1 expression through a miR-217–binding site within the 3'-UTR of SirT1. In young human umbilical vein endothelial cells, human aortic endothelial cells, and human coronary artery endothelial cells, miR-217 induces a premature senescence-like phenotype and leads to an impairment in angiogenesis via inhibition of SirT1 and modulation of FoxO1 (forkhead box O1) and endothelial nitric oxide synthase acetylation. Conversely, inhibition of miR-217 in old endothelial cells ultimately reduces senescence and increases angiogenic activity via an increase in SirT1. miR-217 is expressed in human atherosclerotic lesions and is negatively correlated with SirT1 expression and with FoxO1 acetylation status.
Conclusions: Our data pinpoint miR-217 as an endogenous inhibitor of SirT1, which promotes endothelial senescence and is potentially amenable to therapeutic manipulation for prevention of endothelial dysfunction in metabolic disorders.|
|Description: ||This is the author’s final draft of the paper. The final published version is available at the DOI below:|
|Appears in Collections:||Published Articles, Dept. of Cardiovascular Sciences|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.